TABLE 2

Country policies and recommendations on HIV testing, tuberculosis (TB) screening, latent TB infection (LTBI) testing, antiretroviral treatment (ART) and co-trimoxazole preventive treatment (CPT) based on the responses from 47 countries

TB incidenceHIV incidenceTotal
HighLow
All countriesHigh11+14§25
Low2ƒ20##22
Policies and recommendations
 HIV test in TB patients#
  All patientsHigh11 (100)13 (93)24
Low1 (50)15 (75)16
  Selected patientsHigh0 (0)1 (7)1
Low0 (0)5 (25)5
 TB screening in PLHIV
  All patientsHigh11 (100)11 (79)22
Low2 (100)10 (50)12
  Selected patientsHigh0 (0)3 (21)3
Low0 (0)10 (50)10
 LTBI screening in PLHIV
  All patientsHigh5 (45)13 (93)18
Low2 (100)10 (50)12
  Selected patientsHigh3 (27)1 (7)4
Low0 (0)9 (45)9
  Not recommendedHigh3 (27)0 (0)3
Low0 (0)1 (5)1
 Start of ART in TB/HIV patients
  All patientsHigh11 (100)13 (93)24
Low1 (50)18 (90)19
  Selected patientsHigh0 (0)1 (7)1
Low1 (50)2 (10)3
 CPT of TB/HIV patients
  All patientsHigh8 (73)8 (57)16
Low0 (0)3 (15)3
  Selected patientsHigh2 (18)0 (0)2
Low1 (50)4 (20)5
  Not recommendedHigh0 (0)6 (43)6
Low0 (0)10 (50)10

Data are presented as n or n (% of total number of countries in the category). PLHIV: people living with HIV. #: one country did not respond to this question. : five respondents were not familiar with their country's recommendation for CPT. +: high TB, high HIV: Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Malta, Moldova, Portugal, Ukraine, Uzbekistan. §: high TB, low HIV: Albania, Armenia, Azerbaijan, Belgium, Bulgaria, Croatia, Kosovo, Lithuania, Macedonia, Montenegro, Romania, Serbia, Spain, Turkey. ƒ: low TB, high HIV: Ireland, Luxembourg. ##: low TB, low HIV: Austria, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Israel, Italy, Monaco, the Netherlands, Norway, Slovakia, Slovenia, Sweden, Switzerland, the UK.